Allena Pharmaceuticals (ALNA) Annual Balance Sheets

Annual · GAAP · USD millions
Access ALNA quarterly Balance Sheets →
The balance sheet data below highlights changes in Allena Pharmaceuticals's financial position over recent quarters.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2021)
(Dec 31 2020) (Dec 31 2019) (Dec 31 2018) (Dec 31 2017)
Assets
Cash & cash equivalent29.99
Cash & Short-term Investments29.00
Prepaid Expense And Other Assets Current3.02
Total Current Assets33.01
Equipment/Property/Plant Net1.17
Other Assets, Noncurrent0.58
Operating Lease Right Of Use Asset0.46
Total Assets34.76
Liabilities
Accounts Payable, Current AC1.03
Accrued Liabilities, Current AC4.48
Loans Payable, Current NO9.85
Total Current Liabilities15.68
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.32
Operating Lease Liability Noncurrent0.21
Total Liabilities15.89
Stockholders' Equity
Common Stock Value0.08
Additional Paid In Capital Common Stock265.24
Retained Earnings / Accumulated Deficit-246.45
Other Equity0.00
Common Stockholder's Equity18.87
Total Stockholder's Equity18.87
Liabilities & Stockholder's Equity34.76
4 historic quarters locked

Sign in to unlock the full Allena Pharmaceuticals balance sheet history.

About Allena Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-22-017398

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License